The Role of Nursing and Pharmacy in Enhancing Daily Medication Adherence Among Thyroid Patients

Authors

  • Almutlaq Ahlam Mohammed T
  • Mohammed Hamoud ALSAADI
  • Maryam Muallaq Ajjaj ALRUWAILI
  • Alanazı, Khulood Naıf K
  • Alenezı, Abdulmajıd Ayed N
  • Faza Thanı Awad ALRUWAILI
  • Meshal Naıf Jayız ALRUWAILI
  • Mohammed Moteeb K ALENEZI
  • Asma Taysir ALSALEEM
  • Adel Raffaa Shehab ALANAZI
  • Almıglad, Budur Turkı M

DOI:

https://doi.org/10.22399/ijcesen.3947

Keywords:

nursing, pharmacy, medication adherence, thyroid patients, education, support

Abstract

In managing thyroid conditions, adherence to prescribed medication regimens is crucial for achieving optimal health outcomes. Nurses and pharmacists play pivotal roles in enhancing medication adherence among thyroid patients by providing tailored education, support, and monitoring. Nurses are often the first point of contact for patients and can assess their understanding of treatment plans, address concerns, and encourage adherence through effective communication and follow-up care. By fostering a therapeutic relationship, nurses can empower patients to engage actively in their treatment, ultimately improving their commitment to lifestyle changes and medication intake. Pharmacists also contribute significantly to enhancing medication adherence through their expert knowledge of pharmaceuticals and their side effects. They can ensure that patients receive clear instructions on how and when to take their medications, as well as educate them about potential interactions and the importance of consistency, especially for thyroid medications that often require strict timing. Additionally, pharmacists can provide medication synchronization services, which help streamline the medication refilling process, reducing the risk of missed doses. By collaborating with healthcare providers and actively involving patients in their care plans, both nurses and pharmacists can create a comprehensive support system that enhances adherence to medication regimens among thyroid patients.

References

[1] Taylor PN, Albrecht D, Scholz A, et al. (2018). Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 14(5):301-316. doi:10.1038/nrendo.2018.18

[2] Thayakaran R, Adderley NJ, Sainsbury C, et al. (2019). Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ. 366:l4892. Published 2019 Sep 3. doi:10.1136/bmj.l4892

[3] Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L. (2017). Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSH. J Clin Endocrinol Metab. 102(7):2301-2309. doi:10.1210/jc.2017-00166

[4] Osterberg L, Blaschke T. (2005). Adherence to medication. N Engl J Med. 353(5):487-497. doi:10.1056/NEJMra050100

[5] Bach-Huynh TG, Nayak B, Loh J, Soldin S, Jonklaas J. (2009). Timing of levothyroxine administration affects serum thyrotropin concentration. J Clin Endocrinol Metab. 94(10):3905-3912. doi:10.1210/jc.2009-0860

[6] Brito JP, Ross JS, El Kawkgi OM, et al. (2021). Levothyroxine Use in the United States, 2008-2018. JAMA Intern Med. 181(10):1402-1405. doi:10.1001/jamainternmed.2021.2686

[7] Mastal M, Levine J. (2012). The value of registered nurses in ambulatory care settings: a survey. Nurs Econ. 30(5):295-304.

[8] Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. (2018). Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 8(1):e016982. doi:10.1136/bmjopen-2017-016982

[9] Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. (2010). US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 48(10):923-933. doi:10.1097/MLR.0b013e3181e57962

[10] Streeter SB, Schwartzberg L, Husain N, Johnsrud M. (2011). Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 7(3 Suppl):46s-51s. doi:10.1200/JOP.2011.000316

[11] Chia LR, Schlenk EA, Dunbar-Jacob J. (2006). Effect of personal and cultural beliefs on medication adherence in the elderly. Drugs Aging. 23(3):191-202. doi:10.2165/00002512-200623030-00002

[12] Dietrich JW, Gieselbrecht K, Holl RW, Boehm BO. (2006). Absorption kinetics of levothyroxine is not altered by proton-pump inhibitor therapy. Horm Metab Res. 38(1):57-59. doi:10.1055/s-2006-924980

[13] Lee SY, Pearce EN. (2022). Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol. 18(3):158-171. doi:10.1038/s41574-021-00604-z

[14] Brito JP, Ross JS, El Kawkgi OM, et al. (2021). Levothyroxine Use in the United States, 2008-2018. JAMA Intern Med. 181(10):1402-1405. doi:10.1001/jamainternmed.2021.2686

[15] Horvat M, Eržen I, Vrbnjak D. (2024). Barriers and Facilitators to Medication Adherence among the Vulnerable Elderly: A Focus Group Study. Healthcare (Basel). 12(17):1723. doi:10.3390/healthcare12171723

[16] Elliott RA, Boyd MJ, Salema NE, et al. (2016). Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ Qual Saf. 25(10):747-758. doi:10.1136/bmjqs-2015-004400

[17] Streeter SB, Schwartzberg L, Husain N, Johnsrud M. (2011). Patient and plan characteristics affecting abandonment of oral oncolytic prescriptions. J Oncol Pract. 7(3 Suppl):46s-51s. doi:10.1200/JOP.2011.000316

[18] Dewalt DA, Berkman ND, Sheridan S, Lohr KN, Pignone MP. (2004). Literacy and health outcomes: a systematic review of the literature. J Gen Intern Med. 19(12):1228-1239. doi:10.1111/j.1525-1497.2004.40153.x

[19] Kruk ME, Schwalbe N. (2006). The relation between intermittent dosing and adherence: preliminary insights. Clin Ther. 28(12):1989-1995. doi:10.1016/j.clinthera.2006.12.011

[20] García-Pérez LE, Alvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. (2013). Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 4(2):175-194. doi:10.1007/s13300-013-0034-y

[21] Mobini S, Allahbakhshian A, Shabanloei R, Sarbakhsh P. (2023). Illness Perception, Self-Efficacy, and Medication Adherence in Patients With Coronary Artery Disease: A Path Analysis of Conceptual Model. SAGE Open Nurs. 9:23779608231171772. doi:10.1177/23779608231171772

[22] Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. (2018). Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 8(1):e016982. Published 2018 Jan 21. doi:10.1136/bmjopen-2017-016982

[23] Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. (2015). The Health Belief Model as an explanatory framework in communication research: exploring parallel, serial, and moderated mediation. Health Commun. 30(6):566-576. doi:10.1080/10410236.2013.873363

[24] Bandura A. (2001). Social cognitive theory: an agentic perspective. Annu Rev Psychol. 52:1-26. doi:10.1146/annurev.psych.52.1.1

[25] Caprara GV. (2011). Advocating an agentic and potentialist view to health psychology. Georgian Med News. (196-197):42-46.

[26] Kardas P, Lewek P, Matyjaszczyk M. (2013). Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 4:91. doi:10.3389/fphar.2013.00091

[27] Elliott RA, Boyd MJ, Salema NE, et al. (2016). Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service. BMJ Qual Saf. 25(10):747-758. doi:10.1136/bmjqs-2015-004400

[28] Conn VS, Ruppar TM. (2017). Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis. Prev Med. 99:269-276. doi:10.1016/j.ypmed.2017.03.008

[29] Nieuwlaat R, Wilczynski N, Navarro T, et al. (2014). Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014(11):CD000011. doi:10.1002/14651858.CD000011.pub4

[30] Bandura A. (1977). Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 84(2):191-215. doi:10.1037//0033-295x.84.2.191

[31] Arshed M, Mahmud AB, Minhat HS, Ying LP, Umer MF. (2023). Effectiveness of mHealth Interventions in Medication Adherence among Patients with Cardiovascular Diseases: A Systematic Review. Diseases. 11(1):41. doi:10.3390/diseases11010041

[32] Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. (2018). Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 8(1):e016982. doi:10.1136/bmjopen-2017-016982

[33] Nieuwlaat R, Wilczynski N, Navarro T, et al. (2014). Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014(11):CD000011. doi:10.1002/14651858.CD000011.pub4

[34] Mastal M, Levine J. (2012). The value of registered nurses in ambulatory care settings: a survey. Nurs Econ. 30(5):295-304.

[35] O'Malley AS, Reschovsky JD. (2011). Referral and consultation communication between primary care and specialist physicians: finding common ground. Arch Intern Med. 171(1):56-65. doi:10.1001/archinternmed.2010.480

[36] Stille CJ, Primack WA. (2011). Interspecialty communication: old problem, new hope?. Arch Intern Med. 171(14):1300. doi:10.1001/archinternmed.2011.326

[37] Thayakaran R, Adderley NJ, Sainsbury C, et al. (2019). Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ. 366:l4892. doi:10.1136/bmj.l4892

[38] Jonklaas J, Bianco AC, Bauer AJ, et al. (2014). Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24(12):1670-1751. doi:10.1089/thy.2014.0028

[39] Negarandeh R, Mahmoodi H, Noktehdan H, Heshmat R, Shakibazadeh E. (2013). Teach back and pictorial image educational strategies on knowledge about diabetes and medication/dietary adherence among low health literate patients with type 2 diabetes. Prim Care Diabetes. 7(2):111-118. doi:10.1016/j.pcd.2012.11.001

[40] Word A, Davidson K, Elsayed E. (2012). Levothyroxine and prednisone causing generalized weakness in a middle-aged man. Case Rep Endocrinol. 2012:616930. doi:10.1155/2012/616930

[41] Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. (2010). US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 48(10):923-933. doi:10.1097/MLR.0b013e3181e57962

[42] O'Malley AS, Reschovsky JD. Referral and consultation communication between primary care and specialist physicians: finding common ground. Arch Intern Med. 2011;171(1):56-65. doi:10.1001/archinternmed.2010.480

Downloads

Published

2024-12-30

How to Cite

Almutlaq Ahlam Mohammed T, Mohammed Hamoud ALSAADI, Maryam Muallaq Ajjaj ALRUWAILI, Alanazı, Khulood Naıf K, Alenezı, Abdulmajıd Ayed N, Faza Thanı Awad ALRUWAILI, … Almıglad, Budur Turkı M. (2024). The Role of Nursing and Pharmacy in Enhancing Daily Medication Adherence Among Thyroid Patients. International Journal of Computational and Experimental Science and Engineering, 10(4). https://doi.org/10.22399/ijcesen.3947

Issue

Vol. 10 No. 4 (2024): IJCESEN

Section

Research Article

License

Copyright (c) 2024 International Journal of Computational and Experimental Science and Engineering

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.